| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 16 |
| 1 | AMLODIPINE | 8 |
| 2 | LENALIDOMIDE | 3 |
| 3 | OLANZAPINE | 3 |
| 4 | PALIPERIDONE | 3 |
| 5 | PALIPERIDONE PALMITATE | 3 |
| 6 | PREGABALIN | 3 |
| 7 | QUETIAPINE | 3 |
| 8 | SOLIFENACIN SUCCIATE | 3 |
| 9 | SOLIFENACIN SUCCINATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE HCL, MENTHOL | 1 | 0.0294 |
| 1 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 2 | SOLIFENACIN SUCCIATE | 3 | 0.0016 |
| 3 | CLOMIPHENE CITRATE | 2 | 0.0013 |
| 4 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 1 | 0.0010 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 7 | LIDOCAINE HCL | 1 | 0.0004 |
| 8 | FINASTERIDE | 16 | 0.0003 |
| 9 | TESTOSTERONE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 17 | 0.0002 |
| 2 | Androgen [EPC] | 3 | 0.0001 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Cholinergic Nicotinic Agonist [EPC] | 2 | 0.0000 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 | 0.0000 |
| 6 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Folate Analog [EPC] | 1 | 0.0000 |
| 8 | Vitamin A [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 8 | 0.0000 |